Literature DB >> 16938483

Detection and localization of calpain 3-like protease in a neuronal cell line: possible regulation of apoptotic cell death through degradation of nuclear IkappaBalpha.

A Marcilhac1, F Raynaud, I Clerc, Y Benyamin.   

Abstract

Calpains are a family of calcium-dependent cysteine proteases involved in major cellular processes including cell death. Their intracellular localization is essential to the understanding of their biological functions. In a previous confocal microscopy study, we observed the presence of a calpain 3-like protein in the mammalian brain. We thus first identified and confirmed the presence of a calpain 3-like protease in a neuronal cell model (NGF-differentiated PC12 cells). The goal of this study was to determine, for the first time in non-muscular cells, the relation between the subcellular localization, activation and function of this protease. We thus investigated its ability to regulate nuclear IkappaBalpha and therefore NF-kappaB activation after cell death stimulation. The IkappaBalpha/NF-kappaB signalling pathway indeed influences the neurodegenerative process by directly affecting gene expression in neurons. In the present study, we found that calpain 3 is present in the cytoplasm and nucleus of neuron-like PC12 cells and could be activated through autolysis in the nuclei of cells undergoing apoptosis after ionomycin treatment. Moreover, in these conditions, we demonstrated formation of the IkappaBalpha/calpain 3 complex and an increase in calpain-dependent IkappaBalpha cleavage products in cell nuclei. Stimulation of calpain-dependent cell death in neuron activated nuclear calpain 3-like protease and IkappaBalpha proteolysis resulted in the regulation of NF-kappaB activation. These data suggest a new mechanism by which calpain 3 activation is able to regulate the IkappaBalpha/NF-kappaB pathway and thus neurodegenerative processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16938483     DOI: 10.1016/j.biocel.2006.06.005

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  8 in total

1.  Inhibition of calpain on oxygen glucose deprivation-induced RGC-5 necroptosis.

Authors:  Shuang Chen; Jie Yan; Hai-Xiao Deng; Ling-Ling Long; Yong-Jun Hu; Mi Wang; Lei Shang; Dan Chen; Ju-Fang Huang; Kun Xiong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

2.  PARP-1: a new player in the asthma field?

Authors:  É Szabó; I Kovács; T Grune; A Haczku; L Virág
Journal:  Allergy       Date:  2011-02-02       Impact factor: 13.146

3.  Knockdown of m-calpain increases survival of primary hippocampal neurons following NMDA excitotoxicity.

Authors:  Matthew B Bevers; Eric Lawrence; Margaret Maronski; Neasa Starr; Michael Amesquita; Robert W Neumar
Journal:  J Neurochem       Date:  2009-01-22       Impact factor: 5.372

4.  Long-term progestin contraceptives (LTPOC) induce aberrant angiogenesis, oxidative stress and apoptosis in the guinea pig uterus: A model for abnormal uterine bleeding in humans.

Authors:  Graciela Krikun; Irina A Buhimschi; Martha Hickey; Frederick Schatz; Lynn Buchwalder; Charles J Lockwood
Journal:  J Angiogenes Res       Date:  2010-04-27

Review 5.  Role of calpains in the injury-induced dysfunction and degeneration of the mammalian axon.

Authors:  Marek Ma
Journal:  Neurobiol Dis       Date:  2013-08-19       Impact factor: 5.996

6.  Calpain-5 mutations cause autoimmune uveitis, retinal neovascularization, and photoreceptor degeneration.

Authors:  Vinit B Mahajan; Jessica M Skeie; Alexander G Bassuk; John H Fingert; Terry A Braun; Heather T Daggett; James C Folk; Val C Sheffield; Edwin M Stone
Journal:  PLoS Genet       Date:  2012-10-04       Impact factor: 5.917

Review 7.  CAPN3: A muscle‑specific calpain with an important role in the pathogenesis of diseases (Review).

Authors:  Lin Chen; Fajuan Tang; Hu Gao; Xiaoyan Zhang; Xihong Li; Dongqiong Xiao
Journal:  Int J Mol Med       Date:  2021-09-22       Impact factor: 4.101

8.  Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma.

Authors:  David T Yang; Ken H Young; Brad S Kahl; Stephanie Markovina; Shigeki Miyamoto
Journal:  Mol Cancer       Date:  2008-05-19       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.